Publication | Open Access

Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients

VaccinationCancer Cohort StudyCancer ImmunosurveillanceMedicineMelanomaImmunologyTumor ImmunityPrior ImmunisationTherapeutic VaccineMalignant MelanomaImmunotherapyOncologyRadiation OncologyCancer Research